Schedule 13D ownership disclosure
Axsome Therapeutics Inc
Security class unavailable · CUSIP: 05464T104
Event date: 2015-11-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,344,500
- Percent of class
- 38.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-083041
- Form type
- SC 13D
- Filer
- Antecip Capital LLC
- CIK
- CIK 1428969
- Filed
- Dec 04, 2015
- Reporting period
- Nov 24, 2015
- Description
- Schedule 13D beneficial ownership